BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10891363)

  • 1. Glucocorticoid effects on NF-kappaB binding in the transcription of the ICAM-1 gene.
    Liden J; Rafter I; Truss M; Gustafsson JA; Okret S
    Biochem Biophys Res Commun; 2000 Jul; 273(3):1008-14. PubMed ID: 10891363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids.
    Caldenhoven E; Liden J; Wissink S; Van de Stolpe A; Raaijmakers J; Koenderman L; Okret S; Gustafsson JA; Van der Saag PT
    Mol Endocrinol; 1995 Apr; 9(4):401-12. PubMed ID: 7659084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of glucocorticoids on tumor necrosis factor alpha-dependent activation of nuclear factor kappaB and expression of the intercellular adhesion molecule 1 gene in osteoblast-like ROS17/2.8 cells.
    Kurokouchi K; Kambe F; Kikumori T; Sakai T; Sarkar D; Ishiguro N; Iwata H; Seo H
    J Bone Miner Res; 2000 Sep; 15(9):1707-15. PubMed ID: 10976991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. I kappaB alpha-independent downregulation of NF-kappaB activity by glucocorticoid receptor.
    Heck S; Bender K; Kullmann M; Göttlicher M; Herrlich P; Cato AC
    EMBO J; 1997 Aug; 16(15):4698-707. PubMed ID: 9303314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation.
    De Bosscher K; Schmitz ML; Vanden Berghe W; Plaisance S; Fiers W; Haegeman G
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13504-9. PubMed ID: 9391055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dual mechanism mediates repression of NF-kappaB activity by glucocorticoids.
    Wissink S; van Heerde EC; vand der Burg B; van der Saag PT
    Mol Endocrinol; 1998 Mar; 12(3):355-63. PubMed ID: 9514153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperative binding and synergistic activation by RelA and C/EBPbeta on the intercellular adhesion molecule-1 promoter.
    Catron KM; Brickwood JR; Shang C; Li Y; Shannon MF; Parks TP
    Cell Growth Differ; 1998 Nov; 9(11):949-59. PubMed ID: 9831247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissociated glucocorticoids with anti-inflammatory potential repress interleukin-6 gene expression by a nuclear factor-kappaB-dependent mechanism.
    Vanden Berghe W; Francesconi E; De Bosscher K; Resche-Rigon M; Haegeman G
    Mol Pharmacol; 1999 Oct; 56(4):797-806. PubMed ID: 10496964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emodin (3-methyl-1,6,8-trihydroxyanthraquinone) inhibits TNF-induced NF-kappaB activation, IkappaB degradation, and expression of cell surface adhesion proteins in human vascular endothelial cells.
    Kumar A; Dhawan S; Aggarwal BB
    Oncogene; 1998 Aug; 17(7):913-8. PubMed ID: 9780008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid receptor activation of the I kappa B alpha promoter within chromatin.
    Deroo BJ; Archer TK
    Mol Biol Cell; 2001 Nov; 12(11):3365-74. PubMed ID: 11694573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent activation of nuclear factor-kappaB in cultured rat hepatic stellate cells involves the induction of potentially novel Rel-like factors and prolonged changes in the expression of IkappaB family proteins.
    Elsharkawy AM; Wright MC; Hay RT; Arthur MJ; Hughes T; Bahr MJ; Degitz K; Mann DA
    Hepatology; 1999 Sep; 30(3):761-9. PubMed ID: 10462383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombin-induced p65 homodimer binding to downstream NF-kappa B site of the promoter mediates endothelial ICAM-1 expression and neutrophil adhesion.
    Rahman A; Anwar KN; True AL; Malik AB
    J Immunol; 1999 May; 162(9):5466-76. PubMed ID: 10228026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How the glucocorticoids suppress immunity.
    Marx J
    Science; 1995 Oct; 270(5234):232-3. PubMed ID: 7569969
    [No Abstract]   [Full Text] [Related]  

  • 14. Human lactoferrin suppresses TNF-α-induced intercellular adhesion molecule-1 expression via competition with NF-κB in endothelial cells.
    Kim CW; Lee TH; Park KH; Choi SY; Kim J
    FEBS Lett; 2012 Feb; 586(3):229-34. PubMed ID: 22226679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gossypol decreases tumor necrosis factor-α-induced intercellular adhesion molecule-1 expression via suppression of NF-κB activity.
    Moon DO; Choi YH; Moon SK; Kim WJ; Kim GY
    Food Chem Toxicol; 2011 Apr; 49(4):999-1005. PubMed ID: 21223991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoid suppression of CX3CL1 (fractalkine) by reduced gene promoter recruitment of NF-kappaB.
    Bhavsar PK; Sukkar MB; Khorasani N; Lee KY; Chung KF
    FASEB J; 2008 Jun; 22(6):1807-16. PubMed ID: 18230685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of endogenous glucocorticoid repressed genes differentially regulated by a glucocorticoid receptor mutant able to separate between nuclear factor-kappaB and activator protein-1 repression.
    Bladh LG; Lidén J; Dahlman-Wright K; Reimers M; Nilsson S; Okret S
    Mol Pharmacol; 2005 Mar; 67(3):815-26. PubMed ID: 15550679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhinovirus infection causes steroid resistance in airway epithelium through nuclear factor κB and c-Jun N-terminal kinase activation.
    Papi A; Contoli M; Adcock IM; Bellettato C; Padovani A; Casolari P; Stanciu LA; Barnes PJ; Johnston SL; Ito K; Caramori G
    J Allergy Clin Immunol; 2013 Nov; 132(5):1075-1085.e6. PubMed ID: 23871663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of steroid action: a novel type of cross-talk between glucocorticoids and NF-kappa B transcription factors.
    van der Saag PT; Caldenhoven E; van de Stolpe A
    Eur Respir J Suppl; 1996 Aug; 22():146s-153s. PubMed ID: 8871061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucocorticoid repression of AP-1 is not mediated by competition for nuclear coactivators.
    De Bosscher K; Vanden Berghe W; Haegeman G
    Mol Endocrinol; 2001 Feb; 15(2):219-27. PubMed ID: 11158329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.